{
  "ptid_time": "029_S_2376_2013-07-15",
  "img_path": "/data/qiuhui/data/adni/images/029_S_2376/2013-07-15/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 75,825 mm³, 61.3% above the reference mean. With a Z-score of 1.78 (96.2th percentile), this represents moderate enlargement; hippocampal volume measures 5,612 mm³, 19.5% below the reference mean. With a Z-score of -1.68 (4.6th percentile), this represents moderate atrophy; whole brain volume measures 1,163,660 mm³, 13.1% above the reference mean. With a Z-score of 1.71 (95.7th percentile), this represents moderate enlargement. ",
  "text_data": "Age is 83.9 years. Gender is Male. Education: 17 years. MMSE: 29.0. MoCA: 24.0. Logical Memory: 4.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.23 SUVR (mild elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows moderate hippocampal atrophy (Z-score -1.68, 4.6th percentile), which is a strong biomarker for Alzheimer’s pathology, alongside mild amyloid elevation (AV45). Despite high MMSE (29), the MoCA (24) suggests subtle cognitive deficits, consistent with early-stage impairment. Ventricular enlargement and whole brain volume changes further support neurodegeneration.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer’s pathology given amyloid positivity and hippocampal atrophy).  \n\n**Confidence:** **High** (due to clear structural and biomarker evidence, though cognitive scores are borderline normal/MCI).  \n\n*Note: Progression to dementia is likely given amyloid burden and hippocampal atrophy, but current cognitive performance does not yet meet dementia criteria.*",
  "timestamp": "2025-07-26T04:25:40.354722"
}